Business
‘We do not have capacity’ to make the Novavax vaccine, says CSL – Sydney Morning Herald
Biotechnology giant CSL has dashed speculation it could make the Novavax coronavirus vaccine onshore at the same time as it produces AstraZeneca’s product.
“At the request of government we have carefully considered our ability to simultaneously manufacture the Novavax vaccine, but unfortunately we do not have the capacity or capability to manufacture two COVID-19 vaccines involving live viruses,” the spokeswoman said.
“CSL remains fully focussed on production of the AstraZeneca vaccine and anticipates that the first locally produced doses of the vaccine will be ready in the second quarter of 2021, subject to regulatory approval.”
A purchasing agreement…
-
Noosa News19 hours agoGaming policy on council’s agenda
-
Noosa News22 hours agoRiders in good hands | Noosa Today
-
Business20 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
Noosa News23 hours agoInside the big change in homebuyer habits during the Christmas holidays